Cosentyx pregnancy category?

What pregnancy category is Cosentyx (secukinumab) listed under?

Cosentyx (secukinumab) is not assigned an FDA “pregnancy category” letter (such as A, B, C, D, or X). Like many newer medicines, it is labeled using the FDA’s current pregnancy-biology narrative format rather than the older category system.

Why you might still see a “pregnancy category” for Cosentyx online

Some websites and older references may show a pregnancy “category” based on outdated labeling or different country/regional systems. For current labeling, the FDA-style narrative description is the most reliable source.

What label language typically matters for pregnancy with biologics like Cosentyx

For biologics, the key pregnancy-related questions in the labeling are usually about:
- Expected fetal exposure during pregnancy
- Any reported outcomes from pregnancy registries or post-marketing experience
- Risk summaries (when available) and clinical guidance for use during pregnancy

If you want, tell me your country (US, UK, Canada, etc.) and whether you’re looking for the official label wording or a simplified risk summary, and I can tailor the answer to that labeling system.